Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
1 hedge funds and large institutions have $32.4K invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 55 closing their positions.
98% less funds holding
Funds holding: 56 → 1 (-55)
100% less capital invested
Capital invested by funds: $1.15B → $32.4K (-$1.15B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 55
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$257M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$176M |
| 3 |
BlackRock
New York
|
-$94M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$70.3M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$60.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$45.4K | -375 | Closed |
|
52
US Bancorp
Minneapolis,
Minnesota
| – | -$36.3K | -300 | Closed |
|
53
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$24K | -200 | Closed |
|
54
Osaic Holdings
Scottsdale,
Arizona
| – | -$13.4K | -111 | Closed |
|
|
PTC
55
Private Trust Company
Cleveland,
Ohio
| – | -$9.32K | -77 | Closed |
|
|
PA
56
Parallel Advisors
San Francisco,
California
| – | -$605 | -5 | Closed |
|
BSX.PRA Hedge Fund Activity: Q2 2023 in Review
1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q2 2023, worth a combined $32.4K — down 100% from $1.15B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of BSX.PRA and 0 opened new positions — a net loss of 55 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was VOYA Investment Management, exiting entirely with an estimated $257M sold.
- 1 institutional investor held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q2 2023, down from 56 in Q1 2023.
- Funds reported $32.4K of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q2 2023 and 55 closed out, a net change of -55 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q2 2023 was VOYA Investment Management, an estimated $257M sold.
Based on aggregated 13F filings for Q2 2023.